Option Care Health, Inc.

NasdaqGS OPCH

Option Care Health, Inc. Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2024: USD 962.05 M

Option Care Health, Inc. Gross Profit is USD 962.05 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -0.32% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Option Care Health, Inc. Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 965.18 M, a 13.81% change year over year.
  • Option Care Health, Inc. Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 848.03 M, a 12.89% change year over year.
  • Option Care Health, Inc. Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 751.17 M, a 11.43% change year over year.
  • Option Care Health, Inc. Gross Profit for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 674.14 M, a 109.22% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
NasdaqGS: OPCH

Option Care Health, Inc.

CEO Mr. John C. Rademacher
IPO Date Aug. 15, 1996
Location United States
Headquarters 3000 Lakeside Drive
Employees 7,500
Sector Health Care
Industries
Description

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Similar companies

INNV

InnovAge Holding Corp.

USD 3.69

1.93%

EHC

Encompass Health Corporation

USD 93.06

0.54%

SGRY

Surgery Partners, Inc.

USD 19.85

-6.19%

ENSG

The Ensign Group, Inc.

USD 133.50

0.88%

PNTG

The Pennant Group, Inc.

USD 26.51

1.07%

AMED

Amedisys, Inc.

USD 91.98

0.01%

UHS

Universal Health Services, Inc.

USD 184.16

-0.85%

SEM

Select Medical Holdings Corporation

USD 18.92

0.64%

EHAB

Enhabit, Inc.

USD 7.74

-0.39%

ADUS

Addus HomeCare Corporation

USD 128.55

1.75%

NHC

National HealthCare Corporation

USD 97.73

0.74%

ACHC

Acadia Healthcare Company, Inc.

USD 44.37

-2.29%

StockViz Staff

January 15, 2025

Any question? Send us an email